Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Diagnosis and Management of Glioblastoma: A Comprehensive Perspective
Vianney Gilard, Abdellah Tebani, Ivana Dabaj, et al.
Journal of Personalized Medicine (2021) Vol. 11, Iss. 4, pp. 258-258
Open Access | Times Cited: 51

Showing 1-25 of 51 citing articles:

Epidermal Growth Factor Receptor Inhibitors in Glioblastoma: Current Status and Future Possibilities
Shawyon Ezzati, S. Salib, Meenakshisundaram Balasubramaniam, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 4, pp. 2316-2316
Open Access | Times Cited: 23
Exploring the Past, Present, and Future of Anti-Angiogenic Therapy in Glioblastoma
Ashley B. Zhang, Khashayar Mozaffari, Brian Aguirre, et al.
Cancers (2023) Vol. 15, Iss. 3, pp. 830-830
Open Access | Times Cited: 33
Advancements in Glioma Care: Focus on Emerging Neurosurgical Techniques
Matteo De Simone, Valeria Conti, Giuseppina Palermo, et al.
Biomedicines (2023) Vol. 12, Iss. 1, pp. 8-8
Open Access | Times Cited: 27
Development of Berberine-Loaded Nanoparticles for Astrocytoma Cells Administration and Photodynamic Therapy Stimulation
Sergio Comincini, Federico Manai, Milena Sorrenti, et al.
Pharmaceutics (2023) Vol. 15, Iss. 4, pp. 1078-1078
Open Access | Times Cited: 21
Presurgical diagnosis of diffuse gliomas in adults: Post-WHO 2021 practical perspectives from radiologists in neuro-oncology units
Albert Pons‐Escoda, Carles Majós, Marion Smits, et al.
Radiología (English Edition) (2024) Vol. 66, Iss. 3, pp. 260-277
Open Access | Times Cited: 6
Targeting brain tumors with innovative nanocarriers: bridging the gap through the blood-brain barrier
Karan Wadhwa, PAYAL CHAUHAN, Shobhit Kumar, et al.
Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics (2024) Vol. 32, Iss. 5, pp. 877-897
Open Access | Times Cited: 6
Advances in Glioblastoma Diagnosis: Integrating Genetics, Noninvasive Sampling, and Advanced Imaging
R. Annie Gough, Randall W. Treffy, Max Krucoff, et al.
Cancers (2025) Vol. 17, Iss. 1, pp. 124-124
Open Access
SV2B/miR-34a/miR-128 axis as prognostic biomarker in glioblastoma multiforme
Denis Mustafov, Safia Siddiqui, Ladislav Klena, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 4
Emerging Approaches in Glioblastoma Treatment: Modulating the Extracellular Matrix Through Nanotechnology
Miguel Horta, Paula Soares, Catarina Leite Pereira, et al.
Pharmaceutics (2025) Vol. 17, Iss. 2, pp. 142-142
Open Access
Comparative Clinical-Imaging and Histogenetic Analysis Between Astrocytoma IDH-Mutant Grade 4 and Glioblastoma IDH-Wildtype—Is There Really a Worse One?
Cristian Ionuț Orășanu, Mariana Aşchie, Mariana Deacu, et al.
Diagnostics (2025) Vol. 15, Iss. 4, pp. 438-438
Open Access
Angiogenesis in Glioblastoma—Treatment Approaches
Agnieszka Nowacka, Maciej Śniegocki, Wojciech Smuczyński, et al.
Cells (2025) Vol. 14, Iss. 6, pp. 407-407
Open Access
Radiation induces M2 polarization of glioma-associated macrophages via upregulation of glutamine synthetases
Yijun Lu, Chen Zhou, Jie Li, et al.
International Immunopharmacology (2025) Vol. 154, pp. 114595-114595
Closed Access
Unique Presentation of Glioblastoma With Acute Onset Symptomatology and Disease Recurrence
Angelo Federico, Alexander A Restum, Chadi Faraj
Cureus (2025)
Open Access
Selectively targeting BCL6 using a small-molecule inhibitor is a potential therapeutic strategy for glioblastoma
Min Wu, Lin Zhang, Weikai Guo, et al.
Genes & Diseases (2025), pp. 101644-101644
Open Access
BRAF Signaling Inhibition in Glioblastoma: Which Clinical Perspectives?
Victoria Bouchè, Giovanni Aldegheri, Carmine Antonio Donofrio, et al.
Frontiers in Oncology (2021) Vol. 11
Open Access | Times Cited: 24
Signaling Pathways of AXL Receptor Tyrosine Kinase Contribute to the Pathogenetic Mechanisms of Glioblastoma
Alberto Repici, Alessio Ardizzone, Fabiola De Luca, et al.
Cells (2024) Vol. 13, Iss. 4, pp. 361-361
Open Access | Times Cited: 3
Survival rate of patient with glioblastoma: a population-based study
Masih Sabouri, Aref Famili Dogonchi, Mehdi Shafiei, et al.
The Egyptian Journal of Neurosurgery : the official publication of the Egyptian Society of Neurological Surgeons/Egyptian journal of neurosurgery (2024) Vol. 39, Iss. 1
Open Access | Times Cited: 3
Exploring Genetic Determinants: A Comprehensive Analysis of Serpin B Family SNPs and Prognosis in Glioblastoma Multiforme Patients
Sohaib Al-Khatib, Ayah N. Al-Bzour, Mohammad N. Almajali, et al.
Cancers (2024) Vol. 16, Iss. 6, pp. 1112-1112
Open Access | Times Cited: 2
Imaging and Liquid Biopsy for Distinguishing True Progression From Pseudoprogression in Gliomas, Current Advances and Challenges
Kaishu Li, Qihui Zhu, Junyi Yang, et al.
Academic Radiology (2024) Vol. 31, Iss. 8, pp. 3366-3383
Open Access | Times Cited: 2
Berberine Photo-Activation Potentiates Cytotoxicity in Human Astrocytoma Cells through Apoptosis Induction
Francesca Carriero, Carolina Martinelli, Fabio Gabriele, et al.
Journal of Personalized Medicine (2021) Vol. 11, Iss. 10, pp. 942-942
Open Access | Times Cited: 16
Enhanced Delivery of Rose Bengal by Amino Acids Starvation and Exosomes Inhibition in Human Astrocytoma Cells to Potentiate Anticancer Photodynamic Therapy Effects
Bianca Slivinschi, Federico Manai, Carolina Martinelli, et al.
Cells (2022) Vol. 11, Iss. 16, pp. 2502-2502
Open Access | Times Cited: 11
Anticancer Activities of 9-chloro-6-(piperazin-1-yl)-11H-indeno[1,2-c] quinolin-11-one (SJ10) in Glioblastoma Multiforme (GBM) Chemoradioresistant Cell Cycle-Related Oncogenic Signatures
Ntlotlang Mokgautsi, Yu‐Cheng Kuo, Sung‐Ling Tang, et al.
Cancers (2022) Vol. 14, Iss. 1, pp. 262-262
Open Access | Times Cited: 9
Intra-lesion injection of activated Natural Killer (NK) cells in recurrent malignant brain tumors
Niloufar Shayan Asl, Maryam Behfar, Rouzbeh Shams Amiri, et al.
International Immunopharmacology (2023) Vol. 120, pp. 110345-110345
Closed Access | Times Cited: 4
Targeting inflammation in glioblastoma: An updated review from pathophysiology to novel therapeutic approaches
Nasser M. Alorfi, Ahmed M. Ashour, Adnan Alharbi, et al.
Medicine (2024) Vol. 103, Iss. 21, pp. e38245-e38245
Open Access | Times Cited: 1
Atypical Presentation of Glioblastoma: A Case Report
Tambi Isaac, Nassir M. Mansour
Cureus (2024)
Open Access | Times Cited: 1
Page 1 - Next Page

Scroll to top